Principal Investigator

Academic Position

Yonsei University College of Medicine, Seoul, Korea (Mar 2021~Present)

• Associate Professor, Dept. of Biomedical Sciences

Yonsei University College of Medicine, Seoul, Korea (Mar 2017~Feb 2021)

• Assistant Professor, Dept. of Biomedical Sciences

Sejong University, Seoul, Korea (Mar 2015~Feb 2017)

• Assistant Professor, Dept. of Bioscience and Biotechnology

Education & Training Background

The Salk Institute for Biological Studies, La Jolla, CA, USA (Aug 2008~Mar 2015)

• Post Doc., Dept. of Gene Expression Laboratory (Advisor: Dr. Ronald M. Evans)

University of Illinois at Urbana-Champaign, IL  USA (Aug 2003~Jun 2008)

• Ph.D., Dept. of Molecular & Integrative Physiology (Advisor: Dr. J. Kim Kemper)

Seoul National University, Seoul, Korea (Mar 1995~Feb 1999)

• B.S., School of Biological Sciences (major in Molecular Biology)

Daewon Foreign Language High School, Seoul, Korea (Mar 1991~Feb 1994)

• Dept. of French

Military Service

Defense of Security Command, Republic of Korea (May 1999~Jul 2001)

• Sergeant (discharged), Secretary of Lieutenant Commanding General

Professional Affiliation

Laboratory Animal Research

• Associate Editor

Clinical and Molecular Hepatology

• Associate Editor

Yonsei Medical Journal

• Editorial Board

BMB Reports

• Editorial Board

Frontiers in Endocrinology

• Review Editor

Patents: Out-Licensing Agreement with Metacrine, Inc. (Nasdaq listed: Sept. 2020)

L/O: Metacrine, Inc. (San Diego, CA) in 2015

• Analogs of Fexaramine and Methods of Making and Using

• Treating Latent Autoimmune Diabetes of Adults with FXR agonists to activate intestinal receptors

• Intestinal FXR agonism enhances GLP-1 signaling to restore pancreatic beta cell function